Russell Investments Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-435
| Closed | -$5.64K | – | 3345 |
|
|
2023
Q4 | $5.64K | Sell |
435
-5,889
| -93% | -$76.3K | ﹤0.01% | 2896 |
|
|
2023
Q3 | $127K | Sell |
6,324
-40
| -0.6% | -$804 | ﹤0.01% | 2581 |
|
|
2023
Q2 | $171K | Buy |
6,364
+72
| +1% | +$1.93K | ﹤0.01% | 2503 |
|
|
2023
Q1 | $367K | Sell |
6,292
-3,452
| -35% | -$201K | ﹤0.01% | 2351 |
|
|
2022
Q4 | $497K | Buy |
9,744
+1,116
| +13% | +$56.9K | ﹤0.01% | 2289 |
|
|
2022
Q3 | $705K | Buy |
8,628
+1,355
| +19% | +$111K | ﹤0.01% | 2093 |
|
|
2022
Q2 | $491K | Buy |
7,273
+3,223
| +80% | +$218K | ﹤0.01% | 2278 |
|
|
2022
Q1 | $447K | Buy |
4,050
+4,003
| +8,517% | +$442K | ﹤0.01% | 2264 |
|
|
2021
Q4 | $4K | Sell |
47
-120
| -72% | -$10.2K | ﹤0.01% | 2984 |
|
|
2021
Q3 | $14K | Sell |
167
-3,344
| -95% | -$280K | ﹤0.01% | 3006 |
|
|
2021
Q2 | $542K | Buy |
3,511
+616
| +21% | +$95.1K | ﹤0.01% | 2565 |
|
|
2021
Q1 | $456K | Sell |
2,895
-834
| -22% | -$131K | ﹤0.01% | 2561 |
|
|
2020
Q4 | $864K | Sell |
3,729
-378
| -9% | -$87.6K | ﹤0.01% | 2179 |
|
|
2020
Q3 | $898K | Buy |
4,107
+2,190
| +114% | +$479K | ﹤0.01% | 2122 |
|
|
2020
Q2 | $543K | Buy |
+1,917
| New | +$543K | ﹤0.01% | 2355 |
|
|
2020
Q1 | – | Sell |
-1,107
| Closed | -$318K | – | 3089 |
|
|
2019
Q4 | $318K | Buy |
+1,107
| New | +$318K | ﹤0.01% | 2560 |
|
|
2018
Q3 | – | Sell |
-293
| Closed | -$75K | – | 2984 |
|
|
2018
Q2 | $75K | Sell |
293
-27
| -8% | -$6.91K | ﹤0.01% | 2768 |
|
|
2018
Q1 | $64K | Hold |
320
| – | – | ﹤0.01% | 2800 |
|
|
2017
Q4 | $47K | Buy |
+320
| New | +$47K | ﹤0.01% | 2873 |
|
|
2017
Q2 | – | Sell |
-4,992
| Closed | -$962K | – | 3000 |
|
|
2017
Q1 | $962K | Buy |
4,992
+2,544
| +104% | +$490K | ﹤0.01% | 2117 |
|
|
2016
Q4 | $343K | Buy |
+2,448
| New | +$343K | ﹤0.01% | 2579 |
|